Tropaeolum majus L. and low dose gamma radiation suppress liver carcinoma development via EGFR-HER2 signaling pathway

Nat Prod Res. 2023 Mar;37(6):1030-1035. doi: 10.1080/14786419.2022.2098958. Epub 2022 Jul 14.

Abstract

Hepatocellular carcinoma (HCC) is one of the most fatal cancers around the world and remain asymptomatic in early stage. An alcoholic extract prepared from leaves of Tropaeolum majus L. (Tropaeolaceae) was assessed for its potential activity against diethylnitrosamine-induced liver carcinoma in vivo. Oral administration of the extract significantly decreased the inflammatory marker translation NF-kB and supressed HCC progression in combination with 0.5 Gy gamma radiation via EGF-HER-2 pathway. Histopathological and immunohistopathological features also showed the recovery of a hepatic architecture. Immunohistochemical study showed the T. majus and LDR enhancement effect on proapoptotic markers (caspase-3 and Bax) and inhibition of anti-apoptotic factor (BCl2). HPLC-DAD-MSn analysis of the extract revealed the annotation of twelve compounds. T. majus could mediate a defensive influence against diethylnitrosamine-induced hepatocarcinogenesis and serve as a respectable option in amelioration of the hepatocellular carcinoma development in combination with low dose of gamma radiation.

Keywords: Hepatocellular carcinoma; Tropaeolum majus L.; apoptosis; diethylnitrosamine.

MeSH terms

  • Apoptosis
  • Carcinoma, Hepatocellular* / chemically induced
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / radiotherapy
  • Diethylnitrosamine / metabolism
  • Diethylnitrosamine / pharmacology
  • ErbB Receptors / metabolism
  • Gamma Rays
  • Liver
  • Liver Neoplasms* / chemically induced
  • Liver Neoplasms* / drug therapy
  • Plant Extracts / chemistry
  • Signal Transduction
  • Tropaeolum* / chemistry
  • Tropaeolum* / metabolism

Substances

  • Plant Extracts
  • Diethylnitrosamine
  • ErbB Receptors